Skip to main content

2014 | OriginalPaper | Buchkapitel

14. Die Patientin mit Hypertonie

verfasst von : K. Bachelier, M. Böhm

Erschienen in: Perikonzeptionelle Frauenheilkunde

Verlag: Springer Berlin Heidelberg

Zusammenfassung

Kardiovaskuläre Erkrankungen sind zwar bei werdenden Müttern selten (0,2–4 %), sie sind aber die häufigste Ursache mütterlicher Sterblichkeit in den westlichen Industrienationen. In Deutschland sind nahezu 30.000 Schwangere jährlich von den teilweise lebensbedrohlichen Komplikationen betroffen. Die arterielle Hypertonie als die häufigste kardiovaskuläre Erkrankung während der Schwangerschaft betrifft 10 % aller schwangeren Frauen und führt signifikant häufiger zu Totgeburten und neonataler Morbidität. Hypertensive Erkrankungen während der Schwangerschaft sind darüber hinaus mit einem Anteil von 15 % die häufigste Ursache für die mütterliche Sterblichkeit.
Literatur
Zurück zum Zitat Bonow RO, Carabello BA, Chatterjee K et al. (2008) Focused update incorporated into the ACC/ AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118: e523–e661. Bonow RO, Carabello BA, Chatterjee K et al. (2008) Focused update incorporated into the ACC/ AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 118: e523–e661.
Zurück zum Zitat Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206–1252PubMedCrossRef Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206–1252PubMedCrossRef
Zurück zum Zitat Cockburn J, Moar VA, Ounsted M, Redman CW (1982) Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1: 647–649PubMedCrossRef Cockburn J, Moar VA, Ounsted M, Redman CW (1982) Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet 1: 647–649PubMedCrossRef
Zurück zum Zitat Coppage KH, Sibai BM (2005) Treatment of hypertensive complications in pregnancy. Curr Pharm Des 11: 749–757PubMedCrossRef Coppage KH, Sibai BM (2005) Treatment of hypertensive complications in pregnancy. Curr Pharm Des 11: 749–757PubMedCrossRef
Zurück zum Zitat Elrad H, Gleicher KJ (1985) Physiologic changs in normal pregnancy. In: Gleicher N (ed) Principles of of medical therapy in pregnancy. New York: Plenum medical, p33 ff. Elrad H, Gleicher KJ (1985) Physiologic changs in normal pregnancy. In: Gleicher N (ed) Principles of of medical therapy in pregnancy. New York: Plenum medical, p33 ff.
Zurück zum Zitat European Society of Gynecology (ESC), Task Force for the Management of Cardiovascular Diseases during Pregnancy (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 32 (24): 3147–3197 European Society of Gynecology (ESC), Task Force for the Management of Cardiovascular Diseases during Pregnancy (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J 32 (24): 3147–3197
Zurück zum Zitat European Society of Hypertension (ESH), European Society of Gynecology (ESC), Task Force for the Management of Arterial Hypertension (2007) 2007 Guidelines for the management of arterial hypertension. Eur Heart J 28: 1462–1536 European Society of Hypertension (ESH), European Society of Gynecology (ESC), Task Force for the Management of Arterial Hypertension (2007) 2007 Guidelines for the management of arterial hypertension. Eur Heart J 28: 1462–1536
Zurück zum Zitat Geva T, Mauer MB, Striker L, Kirshon B, Pivarnik JM (1997) Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am Heart J 133: 53–9PubMedCrossRef Geva T, Mauer MB, Striker L, Kirshon B, Pivarnik JM (1997) Effects of physiologic load of pregnancy on left ventricular contractility and remodeling. Am Heart J 133: 53–9PubMedCrossRef
Zurück zum Zitat Gruppo di Studio Ipertensione in Gravidanza (1998) Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Br J Obstet Gynaecol 105: 718–722 Gruppo di Studio Ipertensione in Gravidanza (1998) Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Br J Obstet Gynaecol 105: 718–722
Zurück zum Zitat Iffy L, McArdle JJ, Ganesh V, Hopp L (1996) Bromocriptine related atypical vascular accidents postpartum dentified through medicolegal reviews. Med Law 15: 127–134PubMed Iffy L, McArdle JJ, Ganesh V, Hopp L (1996) Bromocriptine related atypical vascular accidents postpartum dentified through medicolegal reviews. Med Law 15: 127–134PubMed
Zurück zum Zitat Levine RJ, Ewell MG, Hauth JC, Curet LB, Catalano PM, Morris CD, Choudhary G, Sibai BM (2003) Should the definition of preeclampsia include a risein diastolic blood pressure of ≥15 mm Hg to a level ,90 mm Hg in association with proteinuria? Am J Obstet Gynecol 2000;183:787–792of High Blood Pressure. Hypertension 42: 1206–1252CrossRef Levine RJ, Ewell MG, Hauth JC, Curet LB, Catalano PM, Morris CD, Choudhary G, Sibai BM (2003) Should the definition of preeclampsia include a risein diastolic blood pressure of ≥15 mm Hg to a level ,90 mm Hg in association with proteinuria? Am J Obstet Gynecol 2000;183:787–792of High Blood Pressure. Hypertension 42: 1206–1252CrossRef
Zurück zum Zitat Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P (2003) Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 327: 955–960PubMedCrossRef Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P (2003) Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 327: 955–960PubMedCrossRef
Zurück zum Zitat Mancia G, De Backer G, Dominiczak A et al. (2007) ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25: 1751–1762PubMedCrossRef Mancia G, De Backer G, Dominiczak A et al. (2007) ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 25: 1751–1762PubMedCrossRef
Zurück zum Zitat Marcoux S. Berube S, Brisson J, Fabia J (1992) Histroy of migraine and risk of pregnancy-induced hypertension. Epidemiology 3: 53–56PubMedCrossRef Marcoux S. Berube S, Brisson J, Fabia J (1992) Histroy of migraine and risk of pregnancy-induced hypertension. Epidemiology 3: 53–56PubMedCrossRef
Zurück zum Zitat Regitz-Zagrosek V, Gohlke-Bärwolf C, Geibel-Zehender A, Haass M, Kaemmerer H, Kruck I, Nienaber C (2008) Heart diseases in pregnancy. Clin Res Cardiol 97: 630–65PubMedCrossRef Regitz-Zagrosek V, Gohlke-Bärwolf C, Geibel-Zehender A, Haass M, Kaemmerer H, Kruck I, Nienaber C (2008) Heart diseases in pregnancy. Clin Res Cardiol 97: 630–65PubMedCrossRef
Zurück zum Zitat Shivvers SA, Wians FH Jr, Keffer JH, Ramin SM (1999) Maternal cardiac troponin I levels during normal labor and delivery. Am J Obstet Gynecol 180: 122PubMedCrossRef Shivvers SA, Wians FH Jr, Keffer JH, Ramin SM (1999) Maternal cardiac troponin I levels during normal labor and delivery. Am J Obstet Gynecol 180: 122PubMedCrossRef
Zurück zum Zitat Sibai BM, Mabie WC, Shamsa F, Vilnar MA, Anderson GD (1990) A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 162: 960–967PubMedCrossRef Sibai BM, Mabie WC, Shamsa F, Vilnar MA, Anderson GD (1990) A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol 162: 960–967PubMedCrossRef
Zurück zum Zitat von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA (2000) Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 355: 87–92CrossRef von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA (2000) Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 355: 87–92CrossRef
Metadaten
Titel
Die Patientin mit Hypertonie
verfasst von
K. Bachelier
M. Böhm
Copyright-Jahr
2014
Verlag
Springer Berlin Heidelberg
DOI
https://doi.org/10.1007/978-3-642-38023-5_14

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.